Loading
Kerendia • Nonsteroidal mineralocorticoid receptor antagonist • Kidney function: 15–29 mL/min/1.73m² (or CrCl 15–29)
The recommended dose of Finerenone (Kerendia) at 15–29 mL/min/1.73m² (or CrCl 15–29) — with monitoring notes for kidney disease and dialysis.
10 mg once daily with caution; specialist guidance below eGFR 25.
Limited data below 25 — close potassium monitoring, especially with concurrent RAS blockade or SGLT2i.
Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.
Full Finerenone (Kerendia) kidney guideFinerenone (Kerendia) has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.
Interactive drug-dosing tool